Position in ACAD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$34,595,774
+$6,267,458 QoQ
Shares Held
1,367,422
+7.5% QoQ
Ownership
0.794%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 5%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ACAD ranks #51 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,595,774 | 1,367,422 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $28,328,316 | 1,272,611 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $33,008,988 | 1,235,829 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $27,817,454 | 1,303,536 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $28,097,423 | 1,302,616 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $22,842,285 | 1,375,213 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,613,914 | 1,232,366 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $17,319,878 | 1,126,130 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $18,602,317 | 1,144,758 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $22,036,861 | 1,191,826 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $38,014,502 | 1,214,133 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $25,438,907 | 1,220,677 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $27,856,770 | 1,163,122 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $21,957,745 | 1,166,724 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,946,359 | 1,127,284 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,273,119 | 1,116,939 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,932,787 | 1,130,787 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $28,351,107 | 1,170,566 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,583,608 | 1,224,662 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $21,581,687 | 1,299,319 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $32,674,062 | 1,339,650 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $15,634,747 | 605,998 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $31,935,559 | 597,373 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $24,250,172 | 587,883 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $29,314,654 | 604,800 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $63,269,753 | 1,497,509 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||